Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
Citation
Dixon, B, Smith, R, Campbell, D et al. 2021, 'Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial', The Lancet Respiratory Medicine, vol. 9, no. 4, pp. 360-372.Year
2021ANU Authors
Field of Research
- Intensive Care
